Your browser doesn't support javascript.
loading
Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer.
Liu, Zhuo; Yu, Miao; Fei, Bingyuan; Sun, Jing; Wang, Dongxin.
Afiliación
  • Liu Z; Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130021, China.
  • Yu M; Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130021, China.
  • Fei B; Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130021, China.
  • Sun J; Department of Biochemistry and Molecular Medicine, The George Washington University, Washington, DC 20052, USA.
  • Wang D; Department of Anesthesiology, Jilin Cancer Hospital, Changchun, Jilin 130021, China, dongxingwang759@163.com.
Onco Targets Ther ; 12: 2095-2104, 2019.
Article en En | MEDLINE | ID: mdl-30936724
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Onco Targets Ther Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Onco Targets Ther Año: 2019 Tipo del documento: Article País de afiliación: China